Cambridge Investment Research Advisors, Inc. Moderna, Inc. Transaction History
Cambridge Investment Research Advisors, Inc.
- $29.9 Billion
- Q4 2024
A detailed history of Cambridge Investment Research Advisors, Inc. transactions in Moderna, Inc. stock. As of the latest transaction made, Cambridge Investment Research Advisors, Inc. holds 22,940 shares of MRNA stock, worth $710,222. This represents 0.0% of its overall portfolio holdings.
Number of Shares
22,940
Previous 20,876
9.89%
Holding current value
$710,222
Previous $1.4 Million
31.61%
% of portfolio
0.0%
Previous 0.0%
Shares
22 transactions
Others Institutions Holding MRNA
# of Institutions
925Shares Held
256MCall Options Held
19MPut Options Held
24.3M-
Vanguard Group Inc Valley Forge, PA40.3MShares$1.25 Billion0.03% of portfolio
-
Baillie Gifford & CO38.9MShares$1.2 Billion1.28% of portfolio
-
Black Rock Inc. New York, NY25.6MShares$791 Million0.07% of portfolio
-
State Street Corp Boston, MA17.6MShares$544 Million0.03% of portfolio
-
Theleme Partners LLP London, X07.31MShares$226 Million20.37% of portfolio
About Moderna, Inc.
- Ticker MRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 391,200,000
- Market Cap $12.1B
- Description
- Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...